GEMAYEL GEORGES 4

What Happened Georges Gemayel, a director of Disc Medicine, received a derivative award (option) covering 6,212 shares on 2026-06-18. The reported price is $0.00, so no cash changed hands at grant; the award represents the right to acquire underlying shares subject to vesting. This is a grant of equity compensation rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-18; Filing date (Form 4): 2026-06-23.
• Transaction type/code: A — Grant/Award (derivative).
• Shares/units: 6,212 underlying shares reported. Price shown: $0.00 (no cash paid at grant).
• Shares owned after transaction: Not disclosed in the filing.
• Footnote: The underlying shares vest upon the earlier of (i) the Company's 2027 annual meeting or (ii) the one-year anniversary of the grant date, subject to Gemayel’s continued service on the vesting date.
• Timeliness: The Form 4 was filed five days after the transaction date; Form 4s are typically required within two business days, so this filing appears later than the usual deadline.

Context This was an equity award tied to future vesting rather than an immediate purchase or sale. Such grants are commonly part of director compensation and do not by themselves indicate buying or selling by the insider. The award will only convert into actual stock ownership if and when the vesting conditions are met.